Breadcrumb
NIH Guide: Weekly Index for January 3, 2025
Weekly NIH Guide Notices
January 3, 2025
General Notices
-
Notice of Pre-application Webinar for RFA-AG-25-001, "Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)"
(NOT-AG-24-097)National Institute on Aging
-
Notice of NIBIB Participation in RFA-EY-25-001: "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)"
(NOT-EB-24-021)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Change to Date for Virtual Question & Answer Office Hour for NIGMS Predoctoral Basic Biomedical and Dual-Degree Clinician Scientist Training Programs
(NOT-GM-25-018)National Institute of General Medical Sciences
-
Request for Information on the National Institute on Aging Health Disparities Research Framework
(NOT-AG-24-086)National Institute on Aging
-
Notice Announcing the National Institute of Mental Health (NIMH) Expectations for Collection of Common Data Elements
(NOT-MH-25-055)National Institute of Mental Health
Notice of Changes to Funding Opportunities
-
Notice of Change: NIDA Participation in RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
(NOT-DA-24-064)National Institute on Drug Abuse
-
Notice of change in "Funding Opportunity Goals" for RFA-EY-25-001 "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)"
(NOT-EY-25-004)National Eye Institute
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required)
(NOT-HG-25-015)National Human Genome Research Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required)
(NOT-HG-25-016)National Human Genome Research Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Human Cell Biology of Alzheimer's Disease Genetic Variants
(NOT-AG-24-039)National Institute on Aging
-
Notice of Special Interest (NOSI): Mechanisms Driving Obesity
and Prostate Cancer Risk
(NOT-CA-25-002)National Cancer Institute
-
Notice of Special Interest (NOSI): Research on rare cancers across the cancer control continuum
(NOT-CA-25-010)National Cancer Institute
-
Notice of Special Interest (NOSI): Research to Identify State and Local Policies, Programs, and Strategies that have Contributed to Reductions in Overdose Deaths
(NOT-DA-24-057)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders
(NOT-HL-24-037)National Heart, Lung, and Blood Institute
Funding Opportunities
-
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
(PA-25-147)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
(PA-25-280)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Deafness and Other Communication DisordersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)
(PAR-25-056)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
(PAR-25-089)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
(PAR-25-099)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Not Applicable
-
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
(PAR-25-101)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
(PAR-25-283)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
(PAR-25-284)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
(PAR-25-328)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
(PAR-25-329)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
(PAR-25-331)National Institute on AgingNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
(PAR-25-332)National Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
(PAR-25-337)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
(PAR-25-338)National Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Eye InstituteOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
(PAR-25-347)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
(PAR-25-357)National Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
(PAR-25-362)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): Not Applicable
-
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
(PAR-25-374)National Institute on AgingApplication Receipt Date(s): Multiple dates, see announcement.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
(RFA-CA-25-005)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
(RFA-CA-25-006)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
(RFA-CA-25-007)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)
(RFA-DA-25-074)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster